Patients participating in Merck and Moderna's experimental melanoma vaccine clinical trial received nine doses administered once every three weeks

Cancer & Oncology

Cancer treatment, oncology drug access, hematologic malignancies, and cancer drug policy.

225 claims·158 news stories

Opening sign-in…